Calico (California Life Company) is Alphabet's biotech subsidiary founded in 2013, dedicated to understanding aging and developing interventions to extend healthy human lifespan. The company conducts fundamental research into the biology of aging and age-related diseases. Led by prominent scientists and backed by Google's resources, Calico has partnerships with pharmaceutical companies and academic institutions. The company operates with a long-term research horizon and focuses on translating basic aging research into therapeutic interventions.
Calico has received investment from 1 venture capital firm.
Alphabet's research and development biotech company focused on aging and longevity research.
Calico has received investment from AbbVie. These venture capital firms and investors provide both capital and strategic support.
Calico has raised $2.5B in total funding. The company operates in the Biotech sector.
Calico was founded in 2013 and is headquartered in San Francisco, California.
Calico operates in the Biotech sector. Alphabet's research and development biotech company focused on aging and longevity research.
